Cai Lei’s 2026 Open Letter: ALS Progress Amid Personal Struggle
JD.com’s former VP Cai Lei shares his 2026 health update and progress in international ALS research through an eye-written open letter.
Neurodegenerative Diseases
Read More
Cai Lei’s ALS Breakthrough Sparks Hope in China’s Medical Research
Despite losing his voice, Cai Lei’s AI-driven advocacy has accelerated ALS research in China, yielding 40 clinical pipelines and over 200 treatments. His legacy inspires a new chapter in medical collaboration.
Cai Lei Champions Global ALS Research Despite Personal Setback
Chinese entrepreneur Cai Lei continues advancing global ALS research and patient support despite being ineligible for breakthrough drug Rag-17 due to genetic factors.